Chronic obstructive pulmonary disease: Epidemiologic aspects

Authors

  • L. V. Iakovlieva National University of Pharmacy, Ukraine
  • A. A. Vasylieva National University of Pharmacy, Ukraine
  • I. E. Kuznetsov National University of Pharmacy, Ukraine
  • N. O. Matyashova National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/cphj.14.1294

Keywords:

COPD, morbidity, mortality, losses

Abstract

The research of the main epidemiologic parameters of chronic obstructive pulmonary disease have been carried out within the study using the analytical method of research of evidence based medicine data bases, namely ACP Journal Club, Cochrane Library, Clinical Evedence, PubMed and others. The results of the research have shown that the main epidemiologic parameters of COPD, such as prevalence, morbidity and mortality vary considerably in different countries and sub-populations within a country and usually depend on the tobacco prevalence. The results of this research have shown that the average prevalence rate of COPD within the general population is registered at the level of 7.6%, while for smokers this index reaches 15.4%. The share of COPD in the structure of respiratory diseases was about 11% in Ukraine within the period of 2007-2011. According to the WHO data chronic obstructive pulmonary disease took the fourth position among TOP-10 causes of death in the world – 5.8% of all lethal cases in 2011. Lethality of COPD is about 60% of the total lethality cases in Ukraine. At present COPD is one of the main causes of morbidity and lethality all over the world, which results in a great economic and social loss. According to the WHO by 2020 COPD will have taken the fifth place in the world by the level of economic and social damage.

References

Белевский А.С. // Атмосфера. Аллергол. и пульмонол. – 2003. – №4. – С. 28-30.

Дзюблик Я.О. // Укр. пульмонол. журн. – 2010. – №1. – С. 30-32.

Илькович М.М., Игнатьев В.А. // Самарский мед. журн. – 2006. – №6. – С. 18-20.

Лещенко И.В., Овчаренко С.И. // РМЖ. – 2003. – Т. 4, №11. – С. 38-43.

Antonio A., Sanjay S., Fernando J. // Martinez Proceedings of the American Thoracic Soc. – 2007. – Vol. 4, №7. – Р. 554-564.

Buist A., McBurnie M., Vollmer W. et al. // Lancet. – 2007. – №370. – Р. 745.

Chronic obstructive pulmonary disease (COPD). [Электронный ресурс]. Режим доступа к сайту – http://www.who.int/respiratory/copd/en/

Costs of chronic obstructive pulmonary disease in Spain: estimation from a population-based study // Arch. Bronhopneumol. – 2004. – Vol. 40. – P. 72-77. [Электронный ресурс]. – Режим доступу: http://www.archbronconeumol.оrg/en/ costs -of-chronic-obstructive pulmonary/articulo/13056637/

David M., Halpin M. // Proceedings of the American Thoracic Soc. – 2006. – Vol. 3, №7. – Р. 619-623.

David M. // Proceedings of the American Thoracic Soc. – 2007. – Vol. 4, №7. – Р. 502-506.

Dirkje S. // Proceedings of the American Thoracic Soc. – 2006. – Vol. 3, №5. – Р. 434-439.

Halbert R.J., Natoli J.L., Gano A. et al. // Eur. Respir. J. – 2006. – №28. – Р. 523.

Halpin D. // Arch. Intern. Med. – 2008. – Vol. 160. – P. 2653-2660.

Jensen H.H., Godtfredsen N., Lange P., Vestbo J. // Eur. Respir. J. – 2006. – №28. – Р. 781.

Lopez A., Shibuya K., Rao C. // Eur. Respir. J. – 2006. – №27. – Р. 156.

Rajen N. // American J. of Respiratory and Critical Care Medicine. – 2012. – Vol. 185, №12. – Р. 1252-1254.

Downloads

Published

2014-03-03

Issue

Section

Pharmacoeconomics